Oregon Freeze Dry Opens $7.5 Million Biopharma Facility


New facility will provide lyophilization services

Oregon Freeze Dry (OFD), a lyophilization and freeze-drying company, has opened a new biopharmaceutical development and clinical facility in Albany, OR. The $7.5 million facility is designed to support the development of traditional pharmaceutical active ingredients, combination products, and medical devices, as well as support lyophilization process development.

The Albany facility will also host lyophilization process development and clinical trials, and features environmental controls that can support development of oral drugs. The center is OFD’s fifth facility in the US, and is anticipated to add at least six new positions to a staff of more than 450.

“Our new facility supports the vision of a world where vaccines and medications can bypass a syringe and be administered orally, increasing access to life-changing medicine around the world,” says Joe Folds, OFD’s president and CEO. “We’re ready and eager to collaborate with pharmaceutical companies and support advances in microbial therapeutics, immunotherapy, and cell and gene therapy.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.